MAGL-IN-22
Product Specifications
CAS Number
2720674-71-3
Target
Nrf2, MAGL, NF-κB
Related Pathways
Metabolism, Immunology/Inflammation, NF-κB
Bioactivity
MAGL-IN-22 (Compound 40) is a reversible, competitive, and selective inhibitor of MAGL that is capable of crossing the blood-brain barrier, with an IC50 of 0.34 μM for hMAGL. It exhibits significant antioxidant and anti-inflammatory properties, activating the Nrf2 pathway and markedly suppressing NFκB-mediated inflammation, without inducing cytotoxic effects. MAGL-IN-22 is applicable in research on neurodegenerative diseases, chronic pain, and cancer.
Smiles
O=C(NC1=CC(=CC=C1O)C=2C=CC(O)=C(F)C2)CCCC=3C=CC=CC3
Molecular Formula
C22H20FNO3
Molecular Weight
365.4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400859-500 1x 500 µL
Human Kappa Light Chain (Kap-56), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880177-100 1x 100 µL
CD50 (ICAM-3) (101-1D2), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details